NewAmsterdam Pharma CSO Johannes Jacob Pieter Kastelein reports $1,257,659 share disposal
NAMS•Chief Scientific Officer Johannes Jacob Pieter Kastelein disposed of 50,246 NewAmsterdam Pharma ordinary shares at a weighted average price of $25.03 on Sept. 30, 2026, after acquiring the same number through option exercise. His indirect holdings fell to 69,302 shares.
1. Share disposal
Kastelein disposed of 50,246 ordinary shares at a weighted average price of $25.03 on Sept. 30, 2026. In the same session, he acquired 50,246 ordinary shares through option exercise, and his indirect holdings fell to 69,302 shares.
